Asia Pacific 3D Bioprinting market will grow by 21.9% annually with a total addressable market cap of $7,456.1 million over 2022-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip.
Highlighted with 39 tables and 56 figures, this 130-page report "Asia Pacific 3D Bioprinting Market 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific 3D Bioprinting market in every aspect of the classification from perspectives of Component, Material, Technology, Application, End User, and Country.
Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• 3D Bioprinters
• Bioinks
o Natural Bioinks
o Hybrid Bioinks
o Synthetic Bioinks
Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Living Cells
• Hydrogels
• Extracellular Matrices
• Other Material Types
By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Inkjet 3D Bioprinting
• Laser-assisted Bioprinting
• Magnetic 3D Bioprinting
• Microextrusion Bioprinting
• Other Technologies
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research Application
o Drug Research
o Regenerative Medicine
o 3D Cell Culture
• Clinical Application
o Skin
o Bone and Cartilage
o Blood Vessels
o Other Clinical Applications
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Research Organization & Academic Institutes
• Biopharmaceutical Companies
• Hospitals
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Material and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
3D Bio-printing Solutions
3D Systems Inc.
3DBio Therapeutics
Advanced Solutions Life Sciences LLC (ASI)
Aspect Biosystems Ltd.
Bico Group AB
Brinter
Cellink AB
CollPlant Biotechnologies Ltd.
Cyfuse Biomedical K. K.
Digilab Inc.
EnvisionTEC GmbH (Desktop Metal Inc.)
Foldink Life Science Technologies
GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
Inventia Life Science Pty Ltd.
Nano3D Biosciences Inc.
Organovo Holdings Inc
Pandorum Technologies Pvt. Ltd.
Poietis
Precise Bio
Prellis Biologics
Regemat 3D S.L.
RegenHU SA
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
ROKIT Healthcare, INC.
Stratasys Ltd.
TeVido BioDevices, Inc.
Vivax Bio, LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter's Fiver Forces Analysis 39
3 Segmentation of Asia Pacific Market by Component 43
3.1 Market Overview by Component 43
3.2 3D Bioprinters 45
3.3 Bioinks 48
4 Segmentation of Asia Pacific Market by Material 50
4.1 Market Overview by Material 50
4.2 Living Cells 52
4.3 Hydrogels 53
4.4 Extracellular Matrices 54
4.5 Other Material Types 55
5 Segmentation of Asia Pacific Market by Technology 56
5.1 Market Overview by Technology 56
5.2 Inkjet 3D Bioprinting 58
5.3 Laser-assisted Bioprinting 59
5.4 Magnetic 3D Bioprinting 60
5.5 Microextrusion Bioprinting 61
5.6 Other Technologies 62
6 Segmentation of Asia Pacific Market by Application 63
6.1 Market Overview by Application 63
6.2 Research Application 65
6.2.1 Drug Research 66
6.2.2 Regenerative Medicine 67
6.2.3 3D Cell Culture 68
6.3 Clinical Application 69
6.3.1 Skin 70
6.3.2 Bone and Cartilage 71
6.3.3 Blood Vessels 72
6.3.4 Other Clinical Applications 73
7 Segmentation of Asia Pacific Market by End User 74
7.1 Market Overview by End User 74
7.2 Research Organization & Academic Institutes 76
7.3 Biopharmaceutical Companies 77
7.4 Hospitals 78
7.5 Other End Users 79
8 Asia-Pacific Market 2021-2031 by Country 80
8.1 Overview of Asia-Pacific Market 80
8.2 Japan 83
8.3 China 86
8.4 Australia 88
8.5 India 90
8.6 South Korea 92
8.7 Rest of APAC Region 94
9 Competitive Landscape 96
9.1 Overview of Key Vendors 96
9.2 New Product Launch, Partnership, Investment, and M&A 99
9.3 Company Profiles 100
3D Bio-printing Solutions 100
3D Systems Inc. 102
3DBio Therapeutics 103
Advanced Solutions Life Sciences LLC (ASI) 104
Aspect Biosystems Ltd. 105
Bico Group AB 106
Brinter 107
Cellink AB 108
CollPlant Biotechnologies Ltd. 109
Cyfuse Biomedical K. K. 110
Digilab Inc. 111
EnvisionTEC GmbH (Desktop Metal Inc.) 112
Foldink Life Science Technologies 113
GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH 114
Inventia Life Science Pty Ltd. 115
Nano3D Biosciences Inc. 116
Organovo Holdings Inc 117
Pandorum Technologies Pvt. Ltd. 118
Poietis 119
Precise Bio 120
Prellis Biologics 121
Regemat 3D S.L. 122
RegenHU SA 123
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.) 124
ROKIT Healthcare, INC. 125
Stratasys Ltd. 126
TeVido BioDevices, Inc. 127
Vivax Bio, LLC 128
RELATED REPORTS 129
The 3D Bioprinting Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...
Asia Pacific cutting tools market will grow by 6.0% annually with a total addressable market cap of $163.03 billion over 2024-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for powe...
Asia Pacific paper machine clothing (PMC) market will grow by 5.3% annually with a total addressable market cap of $7.27 billion over 2024-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking p...
Asia Pacific endoscopy devices market will grow by 7.7% annually with a total addressable market cap of $150.27 billion over 2024-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic c...
Asia Pacific digital health and wellness market will grow by 20.8% annually with a total addressable market cap of $3,072.0 billion over 2024-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphon...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Asia Pacific encoder market will grow by 10.6% annually with a total addressable market cap of $18.21 billion over 2024-2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological ...
Asia Pacific specialty coffee market will grow by 14.7% annually with a total addressable market cap of $266.39 billion over 2024-2033. The growth is driven by rising disposable income and urbanization, growing demand for on-the-go coffee, strengthening premium coffee shops, and rising preferences f...